Cost, stigma may drive consumers to illicit market

Barriers to medicinal cannabis scripts reported in new Australian study, which suggests need to make scripts pathway “more accessible, affordable and appealing” Australians who report recent use of non-prescribed cannabis have cited a variety of reasons for not attempting to obtain a script, according to research released today (Friday 20 Sept) by UNSW’s National Drug